What it sells
Hormone health.
Business model breakdown
Buyer: who owns the budget?
Patients pay directly (self-pay, with drug-plan or HSA coverage possible); employers and benefits plan sponsors can buy through the Partnerships / Employers program.
Trigger: what makes them buy now?
UnverifiedSymptoms of hormone imbalance (perimenopause, PCOS, low testosterone, hair loss, weight); employers cite hormone-linked chronic disease and disability claim costs.
Workflow: what inputs become what output?
Online assessment, blood testing, consult with licensed clinician, personalized plan, medication shipped discreetly.
Economics: what it saves and how it charges
Claims 500k+ prescriptions issued, 1M+ biomarkers tested, 88% report symptom improvement in 90 days.
Distribution: how it reaches customers
Direct online plus Partnerships (employers, partners such as Quikcard benefits).
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-01-15 | — | $10M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.